Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced the presentation of clinical data on ARC-520, the company’s prior generation investigational medicine ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA Management Comments

Arrowhead Pharmaceuticals Presents ARC-520 Clinical Data at The International Liver Congress™April 11, 2018 7:00 AM